Bank of Montreal’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-130,224
| Closed | -$14K | – | 5046 |
|
|
2018
Q4 | $14K | Buy |
130,224
+102,019
| +362% | +$66.9K | ﹤0.01% | 3781 |
|
|
2018
Q3 | $48K | Sell |
28,205
-51
| -0.2% | -$91 | ﹤0.01% | 3418 |
|
|
2018
Q2 | $49K | Buy |
28,256
+27,674
| +4,755% | +$47.8K | ﹤0.01% | 3418 |
|
|
2018
Q1 | $1K | Sell |
582
-63,271
| -99% | -$134K | ﹤0.01% | 4136 |
|
|
2017
Q4 | $142K | Sell |
63,853
-51,658
| -45% | -$128K | ﹤0.01% | 2843 |
|
|
2017
Q3 | $335K | Buy |
115,511
+113,330
| +5,196% | +$387K | ﹤0.01% | 2453 |
|
|
2017
Q2 | $10K | Buy |
2,181
+1,599
| +275% | +$6.59K | ﹤0.01% | 3729 |
|
|
2017
Q1 | $3K | Hold |
582
| – | – | ﹤0.01% | 3797 |
|
|
2016
Q4 | $3K | Sell |
582
-32,521
| -98% | -$170K | ﹤0.01% | 3855 |
|
|
2016
Q3 | $182K | Hold |
33,103
| – | – | ﹤0.01% | 2497 |
|
|
2016
Q2 | $126K | Buy |
33,103
+32,940
| +20,209% | +$112K | ﹤0.01% | 2705 |
|
|
2016
Q1 | $0 | Hold |
163
| – | – | ﹤0.01% | 4510 |
|
|
2015
Q4 | $1K | Buy |
163
+119
| +270% | +$725 | ﹤0.01% | 4153 |
|
|
2015
Q3 | $0 | Buy |
+44
| New | +$341 | ﹤0.01% | 4252 |
|
|
2014
Q4 | – | Sell |
-2,000
| Closed | -$6K | – | 4256 |
|
|
2014
Q3 | $6K | Sell |
2,000
-2,070
| -51% | -$7.51K | ﹤0.01% | 3777 |
|
|
2014
Q2 | $16K | Buy |
4,070
+2,070
| +104% | +$8.79K | ﹤0.01% | 3699 |
|
|
2014
Q1 | $11K | Sell |
2,000
-28
| -1% | -$157 | ﹤0.01% | 3658 |
|
|
2013
Q4 | $11K | Hold |
2,028
| – | – | ﹤0.01% | 3390 |
|
|
2013
Q3 | $9K | Hold |
2,028
| – | – | ﹤0.01% | 3470 |
|
|
2013
Q2 | $9K | Buy |
+2,028
| New | +$10.2K | ﹤0.01% | 3331 |
|
Other funds holding SGYP
Bank of Montreal's SGYP Position: Q1 2019 in Review
Bank of Montreal sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 130,224 shares — an estimated $14K sold.
Bank of Montreal first reported a position in SGYP in Q2 2013 and held it in 20 quarters. The position peaked at $335K in Q3 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Bank of Montreal reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Bank of Montreal sold 130,224 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $14K.
- Bank of Montreal first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 20 quarters.
- Bank of Montreal's Synergy Pharmaceuticals, Inc Common Stock position peaked at $335K in Q3 2017.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.